Company intelligence / Profile preview

Levee Medical

Durham, North Carolina, United Statesleveemedical.com ↗

Ownership: Private
Development stage: Phase 2

Overview

The Voro Urologic Scaffold has shown promising early results in feasibility studies, with an outstanding safety profile and early improvements in continence reported by patients. The pivotal ARID II IDE trial was initiated following FDA approval to further evaluate safety and effectiveness. The device remains investigational and not yet approved for sale anywhere.

Therapeutic areas: Men's Health
Modalities: Device
Industry: Implantable Medical Devices

Drug pipeline

1 asset

Voro Urologic Scaffold

Phase 2

Indications: Post-prostatectomy urinary incontinence, Stress urinary incontinence

Beyond the preview

Go deeper on Levee Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Levee Medical.

Explore the full profile